RC
Romeo De Claro
Hematology & Oncology
Credentials: ·
Research
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
Clinical Cancer Research · 2019 · 196 citations
Review · The Lancet Haematology · 2018 · 120 citations
External control arms in oncology: current use and future directions
Review · Annals of Oncology · 2022 · 118 citations
- RP
35 papers
- MT
24 papers
- KN
20 papers
- AF
12 papers
- DP
10 papers
- EP
10 papers
- PK
9 papers
- NG
8 papers